Lonza Group (OTCMKTS:LZAGY) Stock Price Crosses Below Fifty Day Moving Average – Here’s What Happened

Lonza Group Ag (OTCMKTS:LZAGY)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $68.48 and traded as low as $65.28. Lonza Group shares last traded at $65.72, with a volume of 50,480 shares traded.

Analyst Ratings Changes

Several brokerages recently commented on LZAGY. Royal Bank Of Canada raised Lonza Group from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, February 11th. Zacks Research cut shares of Lonza Group from a “hold” rating to a “strong sell” rating in a research note on Wednesday, February 4th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Lonza Group Trading Down 3.0%

The company has a debt-to-equity ratio of 0.42, a current ratio of 2.24 and a quick ratio of 1.77. The business has a 50-day simple moving average of $68.48 and a two-hundred day simple moving average of $68.43.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.